Turner DS - Search Results

1

Diagnostic procedures for catheter malfunction in programmable implantable intraperitoneal insulin infusion devices.

Olsen CL, Turner DS, Iravani M, Waxman K, Selam JL, Charles MA. Olsen CL, et al. Among authors: turner ds. Diabetes Care. 1995 Jan;18(1):70-6. doi: 10.2337/diacare.18.1.70. Diabetes Care. 1995. PMID: 7698051

2

Reduction of severe hypoglycemic events in type I (insulin dependent) diabetic patients using continuous subcutaneous insulin infusion.

Eichner HL, Selam JL, Holleman CB, Worcester BR, Turner DS, Charles MA. Eichner HL, et al. Among authors: turner ds. Diabetes Res. 1988 Aug;8(4):189-93. Diabetes Res. 1988. PMID: 3148381 Clinical Trial.

3

Insulin antibody responses after long-term intraperitoneal insulin administration via implantable programmable insulin delivery systems.

Olsen CL, Chan E, Turner DS, Iravani M, Nagy M, Selam JL, Wong ND, Waxman K, Charles MA. Olsen CL, et al. Among authors: turner ds. Diabetes Care. 1994 Mar;17(3):169-76. doi: 10.2337/diacare.17.3.169. Diabetes Care. 1994. PMID: 8174443

4

Long-term safety and efficacy of programmable implantable insulin delivery systems.

Olsen CL, Liu G, Iravani M, Nguyen S, Khourdadjian K, Turner DS, Waxman K, Selam JL, Charles MA. Olsen CL, et al. Among authors: turner ds. Int J Artif Organs. 1993 Dec;16(12):847-54. Int J Artif Organs. 1993. PMID: 8175202

5

Implantable programmable insulin pumps for the treatment of diabetes.

Waxman K, Turner D, Nguyen ST, Selam JL, Charles MA. Waxman K, et al. Arch Surg. 1992 Sep;127(9):1032-6; discussion 1036-7. doi: 10.1001/archsurg.1992.01420090036006. Arch Surg. 1992. PMID: 1387526

6

Comparison of intraperitoneal and subcutaneous insulin administration on lipids, apolipoproteins, fuel metabolites, and hormones in type I diabetes mellitus.

Selam JL, Kashyap M, Alberti KG, Lozano J, Hanna M, Turner D, Jeandidier N, Chan E, Charles MA. Selam JL, et al. Metabolism. 1989 Sep;38(9):908-12. doi: 10.1016/0026-0495(89)90240-0. Metabolism. 1989. PMID: 2671601

7

Alterations in reverse cholesterol transport associated with programmable implantable intraperitoneal insulin delivery.

Selam JL, Kashyap ML, Gupta AK, Turner D, Wong ND, Lozano JL, Charles MA. Selam JL, et al. Metabolism. 1994 Jun;43(6):665-9. doi: 10.1016/0026-0495(94)90112-0. Metabolism. 1994. PMID: 8201953 Clinical Trial.

8

Comparison of the safety and effectiveness of human and bovine long-acting insulins.

Selam JL, Turner D, Woertz L, Eichner HL, Lauritano A, Charles MA. Selam JL, et al. Diabetes Res. 1989 Nov;12(3):131-4. Diabetes Res. 1989. PMID: 2635094 Clinical Trial.

9

A preliminary trial of the programmable implantable medication system for insulin delivery.

Saudek CD, Selam JL, Pitt HA, Waxman K, Rubio M, Jeandidier N, Turner D, Fischell RE, Charles MA. Saudek CD, et al. N Engl J Med. 1989 Aug 31;321(9):574-9. doi: 10.1056/NEJM198908313210904. N Engl J Med. 1989. PMID: 2761602

10

Dose-Response Association Between Physical Activity (Daily MIMS, Peak 30-Minute MIMS) and Cognitive Function Among Older Adults: NHANES 2011-2014.

Zheng P, Pleuss JD, Turner DS, Ducharme SW, Aguiar EJ. Zheng P, et al. Among authors: turner ds. J Gerontol A Biol Sci Med Sci. 2023 Feb 24;78(2):286-291. doi: 10.1093/gerona/glac076. J Gerontol A Biol Sci Med Sci. 2023. PMID: 35512348

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters